8-K 1 medamicus015175_8k.txt MEDAMICUS, INC. FORM 8K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): December 12, 2001 MedAmicus, Inc. --------------- (Exact name of Registrant as specified in its charter) Minnesota 0-19467 41-1533300 ---------------------------- ------------ ------------------- (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 15301 Highway 55 West Plymouth, Minnesota 55447 ---------------------------- ------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (763) 559-2613 Items 1, 2, 3, 4, 5, 6, and 8 are not applicable and therefore omitted. ITEM 9. REGULATION FD DISCLOSURE --------------------------------- On December 12, 2001, the President and Chief Executive Officer of MedAmicus, Inc. (the "Company"), James D. Hartman, began use of the slide presentation attached hereto as Exhibit 99.1 which summarizes information about the Company, its products, industry and prospects. The information contained in the slides was presented to securities fund managers and securities analysts in individual meetings. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS ------------------------------------------ 99.1 Slide Presentation SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEDAMICUS, INC. By: /s/ James D. Hartman ------------------------------------- President and Chief Executive Officer Dated: December 13, 2001